Adamas Pharma (ADMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,316 | 22,121 | 33,618 | 20,918 | 23,735 |
| Marketable Securities | 82,126 | 101,605 | 94,725 | 91,155 | 89,917 |
| Receivables | 367 | 3 | 34 | 1,689 | 794 |
| Inventories | 1,704 | 425 | N/A | N/A | N/A |
| TOTAL | $179,175 | $126,960 | $130,191 | $115,236 | $116,987 |
| Non-Current Assets | |||||
| PPE Net | 3,132 | 3,110 | 3,107 | 3,138 | 3,156 |
| Investments And Advances | 2,991 | 7,004 | 16,586 | 10,086 | 22,292 |
| Other Non-Current Assets | 878 | 38 | 38 | 38 | 38 |
| TOTAL | $7,001 | $10,152 | $19,731 | $13,262 | $25,486 |
| Total Assets | $186,176 | $137,112 | $149,922 | $128,498 | $142,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,878 | 5,380 | 4,385 | 3,018 | 3,589 |
| Accrued Expenses | 12,385 | 9,539 | 6,396 | 4,937 | 5,867 |
| Other current liabilities | 344 | 292 | 268 | 306 | 287 |
| TOTAL | $16,607 | $15,211 | $11,049 | $8,261 | $9,743 |
| Non-Current Liabilities | |||||
| Long Term Debt | 102,647 | 35,408 | 33,768 | N/A | N/A |
| Other Non-Current Liabilities | 796 | 615 | 1,201 | 492 | 547 |
| TOTAL | $103,443 | $36,023 | $34,969 | $492 | $547 |
| Total Liabilities | $120,050 | $51,234 | $46,018 | $8,753 | $10,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,807 | 22,779 | 22,514 | 22,359 | 22,220 |
| Common Shares | 28 | 27 | 27 | 27 | 27 |
| Retained earnings | -211,699 | -182,342 | -158,982 | -138,237 | -122,209 |
| Other shareholders' equity | -167 | -112 | -183 | -166 | -193 |
| TOTAL | $66,126 | $85,878 | $103,904 | $119,745 | $132,183 |
| Total Liabilities And Equity | $186,176 | $137,112 | $149,922 | $128,498 | $142,473 |